Using AI as a Diagnostic Decision Support Tool to Help the Diagnosis of Skin Disease in Primary Healthcare in Catalonia
Using Artificial Intelligence as a Diagnostic Decision Support Tool to Help the Diagnosis of Skin Disease in Primary Healthcare in Catalonia
1 other identifier
interventional
100
1 country
1
Brief Summary
Background: Dermatological conditions are a relevant health problem. Machine learning models are increasingly being applied to dermatology as a diagnostic decision support tool using image analysis, specially for skin cancer detection and classification. Objective: The objective of this study is to perform a prospective validation of an image analysis ML model, which is capable of screening 44 different skin disease types, comparing its diagnostic capacity with that of General Practitioners (GPs) and dermatologists. Methods: In this prospective study 100 consecutive patients who visit a participant GP with a skin problem in central Catalonia will be recruited, data collection is planned to last 7 months. Skin diseases anonymized pictures will be taken and introduced in the ML model interface, which will return top 5 accuracy diagnosis. The same image will be also sent as a teledermatology consultation, following the current workflow. GP, ML model and dermatologist/s assessments will be compared to calculate the precision, sensitivity, specificity and accuracy of the ML model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2020
CompletedFirst Posted
Study publicly available on registry
September 24, 2020
CompletedStudy Start
First participant enrolled
January 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedMay 5, 2022
March 1, 2022
12 months
August 28, 2020
May 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Sensitivity of the ML model
True positive rate of the ML model
1 year
Specificity of the ML model
True negative rate of the ML model
1 year
Accuracy of the ML model
Ratio of number of correct predictions to the total number of input samples
1 year
Area under the receiver operating characteristic curve of the ML model
Diagnostic ability of the ML model
1 year
Secondary Outcomes (1)
Rate of the eligible participants who agree to participate in the study
1 year
Study Arms (1)
Diagnostic Test: ML model
EXPERIMENTALThe diagnostic capacity of the ML model will be compared with that of the general practitioners and with dermatologist.
Interventions
GP using a smartphone camera will take an image of the skin problem and will use the Autoderm ML interface to upload the anonymized image. The obtained predicted diagnosis will be recorded in case report form.
Eligibility Criteria
You may qualify if:
- Patients who have cutaneous disease reason-for-visit.
- Patients who provide written informed consent.
- Patients who are 18 years of age or older.
You may not qualify if:
- Patients with advanced dementia.
- Patients with a cutaneous lesion which can't be photographed with a smartphone and images with poor quality.
- Patients who have conditions associated with risk of poor protocol compliance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurinalead
- iDoc24collaborator
- Institut Català de la Salutcollaborator
Study Sites (1)
CAP Navàs
Navàs, Barcelona, 08670, Spain
Related Publications (16)
Lim HW, Collins SAB, Resneck JS Jr, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV. The burden of skin disease in the United States. J Am Acad Dermatol. 2017 May;76(5):958-972.e2. doi: 10.1016/j.jaad.2016.12.043. Epub 2017 Mar 1.
PMID: 28259441RESULTSchofield JK, Fleming D, Grindlay D, Williams H. Skin conditions are the commonest new reason people present to general practitioners in England and Wales. Br J Dermatol. 2011 Nov;165(5):1044-50. doi: 10.1111/j.1365-2133.2011.10464.x. Epub 2011 Sep 22.
PMID: 21692764RESULTDokotor.se [Internet]. Survey Telemedicine statistics Dokotor.se, the % of queries that are dermatology related 2019 [cited 2019]
RESULTActivitat assistencial de la xarxa sanitària de Catalunya, any 2012: registre del conjunt mínim bàsic de dades (CMBD). Barcelona: Departament de Salut. 2013.
RESULTLowell BA, Froelich CW, Federman DG, Kirsner RS. Dermatology in primary care: Prevalence and patient disposition. J Am Acad Dermatol. 2001 Aug;45(2):250-5. doi: 10.1067/mjd.2001.114598.
PMID: 11464187RESULTPorta N, San Juan J, Grasa MP, Simal E, Ara M, Querol MA. [Diagnostic agreement between primary care physicians and dermatologists in the health area of a referral hospital]. Actas Dermosifiliogr. 2008 Apr;99(3):207-12. Spanish.
PMID: 18358196RESULTLopez Segui F, Franch Parella J, Girones Garcia X, Mendioroz Pena J, Garcia Cuyas F, Adroher Mas C, Garcia-Altes A, Vidal-Alaball J. A Cost-Minimization Analysis of a Medical Record-based, Store and Forward and Provider-to-provider Telemedicine Compared to Usual Care in Catalonia: More Agile and Efficient, Especially for Users. Int J Environ Res Public Health. 2020 Mar 18;17(6):2008. doi: 10.3390/ijerph17062008.
PMID: 32197434RESULTBorve A, Dahlen Gyllencreutz J, Terstappen K, Johansson Backman E, Aldenbratt A, Danielsson M, Gillstedt M, Sandberg C, Paoli J. Smartphone teledermoscopy referrals: a novel process for improved triage of skin cancer patients. Acta Derm Venereol. 2015 Feb;95(2):186-90. doi: 10.2340/00015555-1906.
PMID: 24923283RESULTFerrer RT, Bezares AP, Manes AL, Mas AV, Gutierrez IT, Llado CN, Estaras GM. [Diagnostic reliability of an asynchronous teledermatology consultation]. Aten Primaria. 2009 Oct;41(10):552-7. doi: 10.1016/j.aprim.2008.11.012. Epub 2009 Jun 5. Spanish.
PMID: 19500880RESULTGomolin A, Netchiporouk E, Gniadecki R, Litvinov IV. Artificial Intelligence Applications in Dermatology: Where Do We Stand? Front Med (Lausanne). 2020 Mar 31;7:100. doi: 10.3389/fmed.2020.00100. eCollection 2020.
PMID: 32296706RESULTEsteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017 Feb 2;542(7639):115-118. doi: 10.1038/nature21056. Epub 2017 Jan 25.
PMID: 28117445RESULTLiu Y, Jain A, Eng C, Way DH, Lee K, Bui P, Kanada K, de Oliveira Marinho G, Gallegos J, Gabriele S, Gupta V, Singh N, Natarajan V, Hofmann-Wellenhof R, Corrado GS, Peng LH, Webster DR, Ai D, Huang SJ, Liu Y, Dunn RC, Coz D. A deep learning system for differential diagnosis of skin diseases. Nat Med. 2020 Jun;26(6):900-908. doi: 10.1038/s41591-020-0842-3. Epub 2020 May 18.
PMID: 32424212RESULTKamulegeya L, Bwanika J, Okello M, Rusoke D, Nassiwa F, Lubega W, Musinguzi D, Borve A. Using artificial intelligence on dermatology conditions in Uganda: a case for diversity in training data sets for machine learning. Afr Health Sci. 2023 Jun;23(2):753-763. doi: 10.4314/ahs.v23i2.86.
PMID: 38223594RESULTEvaluation of the diagnostic accuracy of an online artificial intelligence app for skin disease diagnosis. Alexander Larson, Degree Project in Medicine, Sahlgrenska University Hospital Department of Dermatology and Venereology, Gothenburg, Sweden 2018.
RESULTBrinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Holland-Letz T, Utikal JS, von Kalle C; Collaborators. Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task. Eur J Cancer. 2019 May;113:47-54. doi: 10.1016/j.ejca.2019.04.001. Epub 2019 Apr 10.
PMID: 30981091RESULTHaenssle HA, Fink C, Schneiderbauer R, Toberer F, Buhl T, Blum A, Kalloo A, Hassen ABH, Thomas L, Enk A, Uhlmann L; Reader study level-I and level-II Groups; Alt C, Arenbergerova M, Bakos R, Baltzer A, Bertlich I, Blum A, Bokor-Billmann T, Bowling J, Braghiroli N, Braun R, Buder-Bakhaya K, Buhl T, Cabo H, Cabrijan L, Cevic N, Classen A, Deltgen D, Fink C, Georgieva I, Hakim-Meibodi LE, Hanner S, Hartmann F, Hartmann J, Haus G, Hoxha E, Karls R, Koga H, Kreusch J, Lallas A, Majenka P, Marghoob A, Massone C, Mekokishvili L, Mestel D, Meyer V, Neuberger A, Nielsen K, Oliviero M, Pampena R, Paoli J, Pawlik E, Rao B, Rendon A, Russo T, Sadek A, Samhaber K, Schneiderbauer R, Schweizer A, Toberer F, Trennheuser L, Vlahova L, Wald A, Winkler J, Wolbing P, Zalaudek I. Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists. Ann Oncol. 2018 Aug 1;29(8):1836-1842. doi: 10.1093/annonc/mdy166.
PMID: 29846502RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 28, 2020
First Posted
September 24, 2020
Study Start
January 15, 2021
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
May 5, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- End of the study
- Access Criteria
- Information will be published in international scientific journals
The protocol will be published.